Treatment of murine disseminated candidiasis with L-743,872

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1775-1777

  Graybill, John R ^a,b   Najvar, Laura K ^a,b   Luther, Michael F ^a   Fothergill, Annette W ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE; PNEUMOCANDIN DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG POTENCY; DRUG RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0030743451     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1775     Document Type: Article

References (21)

1. Angiolella, L., N. Simonetti, and A. Cassone. 1994. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans. J. Antimicroh. Chemother. 33:1137-1146.
2. Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob. Agents Chemother. 39:1070-1076.
3. Bartizal, K. F., G. Abruzzo, C. Trainor, D. Krupa, K. Nollstadt, D. Schmatz, R. Schwartz, M. Hammond, J. Balkovec, and F. Vanmiddlesworth. 1992. In vitro antifungal activities and in vivo efficacies of 1,3-β-D-glucan synthesis inhibitors L-671,329, L-646,991. tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob. Agents Chemother. 36:1648-1657.
4. Fisher, M. A., S.-H. Shen, J. Haddad, and W. F. Tarry. 1989. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 33:1443-1446.
5. Graybill, J. R., L. K. Najvar, J. D. Holmberg, A. Correa, and M. F. Luther. 1995. Fluconazole treatment of Candida albicans in mice: does in vitro susceptibility predict in vitro response? Antimicrob. Agents Chemother. 39:2197-2200.
6. Hall, G. S., C. Myles, K. J. Pratt, and J. A. Washington. 1988. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis. Antimicrob. Agents Chemother. 32:1331-1335.
7. Heinic, G. S., D. A. Stevens, D. Greenspan, L. A. MacPhail, C. L. Dodd, S. Stringari, W. M. Strull, and H. Hollander. 1993. Fluconazole-resistant Candida in AIDS patients. Oral Surg. Oral Med. Oral Pathol. 76:711-715.
8. Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, R. A. Zambias, G. Abruzzo, K. Bartizal, O. B. McManus, and M. L. Garcia. 1994. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38:2750-2757.
9. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-βn-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
10. Lee, J. W., P. Kelly, J. Lecciones, D. Coleman, R. Gordee, P. A. Pizzo, and T. J. Walsh. 1990. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits. Antimicrob. Agents Chemother. 34:2240-2245.
11. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts: proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Newman, S. L., T. P. Flanigan, A. Fisher, M. G. Rinaldi, M. Stein, and K. Vigilante. 1994. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin. Infect. Dis. 19:684-686.
13. Persons, D. A., M. Laughlin, D. Tanner, J. Perfect, J. P. Gockerman, and J. W. Hathorn. 1993. Fluconazole and Candida krusei fungemia. N. Engl. J. Med. 325:1315.
14. Redding, S., J. Smith, M. Farinacci, M. G. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
15. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, R. G. Washburn, W. M. Scheld, A. W. Karchmer, A. P. Dine, M. J. Levenstein, and C. D. Webb. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
16. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
17. Rouse, M. S., B. M. Tallan, J. M. Steckelberg, N. K. Henry, and W. R. Wilson. 1992. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob. Agents Chemother. 36:56-58.
18. Sangeorzan, J. A., S. F. Bradley, X. He, L. T. Zarins, G. L. Ridenour, R. N. Tiballi, and C. A. Kauffman. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97:339-346.
19. Van 'T Wout, J. W., H. Mattie, and R. Van Furth. 1989 Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob. Agents Chemother. 33:147-151.
20. Velez, J. D., R. Allendoerfer, M. Luther, M. G. Rinaldi, and J. R. Graybill. 1993. Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J. Infect. Dis. 168:508-510.
21. White, A., and M. B. Goetz. 1994. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin. Infect. Dis. 19:687-692.